title: Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013.
abstract: We describe a case of vaccine-associated measles in a two-year-old patient from British Columbia, Canada, in October 2013, who received her first dose of measles-containing vaccine 37 days prior to onset of prodromal symptoms. Identification of this delayed vaccine-associated case occurred in the context of an outbreak investigation of a measles cluster.
authors: Fraser Health Authority, Surrey, British Columbia, Canada.
authors: M
authors: M
authors: Murti
authors: M
authors: M
authors: Krajden
authors: M
authors: M
authors: Petric
authors: J
authors: J
authors: Hiebert
authors: F
authors: F
authors: Hemming
authors: B
authors: B
authors: Hefford
authors: M
authors: M
authors: Bigham
authors: P
authors: P
authors: Van Buynder
mesh_terms: D001955:British Columbia; D002170:Canada; D002675:Child, Preschool; D005076:Exanthema / Q000209:etiology / Q000821:virology; D005260:Female; D005334:Fever / Q000209:etiology; D006801:Humans; D008457:Measles / Q000175:diagnosis* / Q000276:immunology / Q000517:prevention & control / Q000821:virology; D022542:Measles-Mumps-Rubella Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D013997:Time Factors
chemical_list: D022542:Measles-Mumps-Rubella Vaccine